Otonomy Announces Presentation of OTO-413 Clinical Results at AAO-HNS Annual Meeting
September 27 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced the presentation of previously
disclosed clinical results from the successful OTO-413 Phase 1/2
trial at the upcoming American Academy of Otolaryngology – Head and
Neck Surgery (AAO-HNS) Annual Meeting to be held in Los Angeles
October 3-6, 2021. The oral presentation will be delivered on
October 3, 2021 at 3:15 p.m. PT by Peter G. Volsky, M.D., Assistant
Professor of Otology and Neurotology at Eastern Virginia Medical
School. Dr. Volsky was an investigator in the trial during his
prior clinical service with South Florida ENT Associates.
“Difficulty understanding conversations in a noisy environment
is a common complaint of patients presenting for hearing loss
treatment including patients with noise-induced and age-related
hearing loss,” said David A. Weber, Ph.D., president and CEO of
Otonomy. “Presentation of these positive clinical results for
OTO-413 highlights its potential treatment benefit for this large
population of patients with speech-in-noise hearing
impairment.”
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs with a focus on hearing loss and tinnitus. For
additional information please visit www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor Inquiries:Westwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024